Table 6.
Antibiotic | Antibiotic Resistance |
Biofilm Formation | % CoPS * |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Strong | Medium | Weak | ||||||||||
Quantity of Isolates | No. of Isolates | |||||||||||
Total No |
% | Total No |
CoPS | CoNS | Total No |
CoPS | CoNS | Total No |
CoPS | CoNS | ||
Vancomycin | 14 | 21 | 8 | 6 | 2 | 5 | 4 | 1 | 1 | 1 | 0 | 79 |
Amox/clav | 39 | 59 | 19 | 8 | 11 | 14 | 7 | 7 | 6 | 5 | 1 | 51 |
Erythpomycin | 43 | 65 | 17 | 11 | 6 | 17 | 9 | 8 | 9 | 8 | 1 | 65 |
Trimeth/sulf | 29 | 44 | 10 | 6 | 4 | 12 | 8 | 4 | 7 | 7 | 0 | 72 |
Imipenem | 33 | 50 | 17 | 7 | 10 | 14 | 7 | 7 | 2 | 1 | 1 | 45 |
Oxacillin | 61 | 92 | 28 | 18 | 10 | 22 | 15 | 7 | 11 | 10 | 1 | 70 |
Ceftriaxone | 47 | 71 | 20 | 13 | 5 | 18 | 15 | 4 | 9 | 8 | 0 | 77 |
Clindamycin | 45 | 68 | 19 | 10 | 9 | 18 | 13 | 6 | 8 | 8 | 1 | 69 |
* Total no. of CoPS isolates in biofilm-forming isolates/total no. of antibiotic resistant isolates. The bold numbers indicate the prevalence of CoPS in comparison with CoNS.